Thanks Everyone, there is some interesting points that have come...

First 43 Last

Share
Profile

Follow
big finn

360 Posts.

89

16/03/19

18:50

Post #: 37785898
Share

Originally posted by big finn: ↑

Is the new CGB Business plan Vastly different from what was proposed in the First Prospectus dated 27 September 2018?

I personally think CGB have vastly changed what was offered in the first prospectus, and as such the money raised (Funds) from the Capital Raise should be returned to all applicants and a complete new Prospectus issued showing the new direction the company (CGB) are taking for the future.

There have been numerous changes from the First prospectus dated 27th September 2018 up until the last 12th supplementary prospectus dated 22 February 2019, that in my opinion should warrant all the Twelve Prospectuses being reviewed, and as such I will be writing to the ASX and ASIC requesting they review the prospectuses and announcement made by Cann Global LTD during this time period.

In my Opinion some of the reasons I think a review is needed is because of (1) the major part of the Medcan Deal proposed in the first prospectus has changed, in particular not going through with the Growing facility fit out, (2) deciding to direct some of the funds raised from the Cap Raise to the New Biohealth deal, along with the CGB saying they saving of Million of Dollars from the new deal "This new arrangement will return a multi-million-dollar saving to the Company in manufacturingcosts".

If anybody would like to add any points they see as valid reasons why this offer should be reviewed, I would like to hear them and add them to my letter to the ASX and ASIC.
If anybody has negative comments please refrain from commenting on this post please, as it's not my intent to flame or bait anybody.

Cheers
Finn

Expand

Thanks Everyone, there is some interesting points that have come out of this discussion that I will raise in my letter to ASIC and the ASX .

CGB Price at posting: 3.7¢ Sentiment: Sell Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

HotCopper Highlights: Your most watched stocks for Week 48, 2024

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

There are more pages in this discussion • 30 more messages in this thread...

First 43 Last

Add CGB (ASX) to my watchlist

Thanks Everyone, there is some interesting points that have come...

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor